Gluten-Free Labeling of Food Products Expermental Study

Forms and Documents

Document	Type	Status	Availability
0656-non sub change-gluten free screenshots.doc	Supplementary Document	Uploaded 2010-03-04	Available
0656 Justificaton - non sub change.doc	Justification for No Material/Nonsubstantive Change	Uploaded 2010-03-04	Repair queued

IC Document Collections

IC ID	Collection	Type	Status	Form
191594	Draft Online Questionnare With Convenience Sample	Other-Questionnaire	Modified
191593	Draft Online Panel Questionnaire	Other-Questionnaire	Modified
191592	Draft Paper Questionnaire	Other-Questionnaire	Modified
191591	Online Pre-Test	Other-Pre Test	Modified
191590	Telephone Paticipant Screener	Other-Screener	Modified
191589	Online Participant Screener	Other-Screener	Modified

ICR Details

OMB Control No: 0910-0656	ICR Reference No: 201003-0910-001
Status: Historical Active	Previous ICR Reference No: 200912-0910-004
Agency/Subagency: HHS/FDA	Agency Tracking No:
Title: Gluten-Free Labeling of Food Products Expermental Study
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 04/21/2010
	Date Received in OIRA: 03/04/2010
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	02/28/2013	02/28/2013	02/28/2013
Responses	17,140	0	17,140
Time Burden (Hours)	2,015	0	2,015
Cost Burden (Dollars)	0	0	0

---

Abstract: Under section 903b of the Federal food Drug and Cosmetic Act (the act),(21 U.S.C.393 (b)(2), FDA is authorized to conduct research relating to foods and to conduct educational and public information programs relating to the safety of the nations food supply. The 'Gluten - Free Labeling of Food Products Experimental study" will collect infomationfrom both consumers who have celiac disease or gluten intolerance and those who do not have either condition. The purpose of the study is to guage perceptions of characteristics related to claims of "gluten free." Further, the results of this study will be used to help FDA define how gluten-free terms can be used on food product labels.

---

Authorizing Statute(s): US Code: 21 USC 393(b)(2) Name of Law: null
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	74 FR 9822	06/06/2009
30-day Notice:	Federal Register Citation:	Citation Date:
	74 FR 59188	11/17/2009
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 6

IC Title	Form No.	Form Name
Online Participant Screener
Telephone Paticipant Screener
Online Pre-Test
Draft Paper Questionnaire
Draft Online Panel Questionnaire
Draft Online Questionnare With Convenience Sample

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	17,140	17,140	0	0	0	0
Annual Time Burden (Hours)	2,015	2,015	0	0	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $159,000

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 03/04/2010

---